Wei Lin

1.7k total citations
99 papers, 1.1k citations indexed

About

Wei Lin is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Epidemiology. According to data from OpenAlex, Wei Lin has authored 99 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Molecular Biology, 27 papers in Pulmonary and Respiratory Medicine and 17 papers in Epidemiology. Recurrent topics in Wei Lin's work include Vasculitis and related conditions (19 papers), Renal Diseases and Glomerulopathies (9 papers) and Liver Disease Diagnosis and Treatment (7 papers). Wei Lin is often cited by papers focused on Vasculitis and related conditions (19 papers), Renal Diseases and Glomerulopathies (9 papers) and Liver Disease Diagnosis and Treatment (7 papers). Wei Lin collaborates with scholars based in China, Australia and United States. Wei Lin's co-authors include Mark A. White, Xiaodong Cheng, Yuanliang Yan, Zhijie Xu, Chunlin Ou, Xiangcheng Xiao, Shuangshuang Zeng, Ting Meng, Yong Zhong and Yu‐Qiu Zhang and has published in prestigious journals such as PLoS ONE, Cancer Research and Scientific Reports.

In The Last Decade

Wei Lin

86 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wei Lin China 19 431 284 152 150 147 99 1.1k
Qingchun Zeng China 24 835 1.9× 278 1.0× 305 2.0× 88 0.6× 283 1.9× 113 2.0k
Jill Moser Netherlands 24 763 1.8× 105 0.4× 253 1.7× 249 1.7× 149 1.0× 62 1.7k
Elizabeth Kuo United States 12 366 0.8× 171 0.6× 91 0.6× 120 0.8× 51 0.3× 15 872
Laura Márquez‐Expósito Spain 15 400 0.9× 93 0.3× 171 1.1× 269 1.8× 77 0.5× 31 916
Fernando de la Cuesta Spain 25 899 2.1× 144 0.5× 188 1.2× 242 1.6× 155 1.1× 67 1.6k
Carine M. Boustany‐Kari United States 17 407 0.9× 104 0.4× 108 0.7× 416 2.8× 156 1.1× 20 1.3k
Julian A. Marschner Germany 20 654 1.5× 272 1.0× 457 3.0× 426 2.8× 150 1.0× 53 1.5k
Martin Kömhoff Germany 25 730 1.7× 248 0.9× 257 1.7× 272 1.8× 168 1.1× 55 2.0k
Stephen I‐Hong Hsu United States 22 416 1.0× 112 0.4× 190 1.3× 419 2.8× 188 1.3× 39 1.5k
Chun‐Tao Lei China 16 353 0.8× 74 0.3× 145 1.0× 310 2.1× 75 0.5× 26 908

Countries citing papers authored by Wei Lin

Since Specialization
Citations

This map shows the geographic impact of Wei Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei Lin more than expected).

Fields of papers citing papers by Wei Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wei Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei Lin. The network helps show where Wei Lin may publish in the future.

Co-authorship network of co-authors of Wei Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Wei Lin. A scholar is included among the top collaborators of Wei Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wei Lin. Wei Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lin, Wei, et al.. (2025). Targeted Therapy for Idiopathic Inflammatory Myopathy. Journal of Cachexia Sarcopenia and Muscle. 16(6). e70143–e70143.
2.
Zhang, Lin, Junxi Wang, Ye Xu, et al.. (2025). Akkermansia muciniphila relieves inflammatory response in DSS-induced ulcerative colitis in mice through regulating macrophage polarization via SCFAs-SLC52A2/FFAR2 pathway. Naunyn-Schmiedeberg s Archives of Pharmacology. 398(7). 8695–8711. 2 indexed citations
3.
4.
Shen, Chanjuan, Ting Meng, Wei Lin, et al.. (2024). Clinical features and prognosis of ANCA-associated vasculitis patients who were double-seropositive for myeloperoxidase-ANCA and proteinase 3-ANCA. Clinical and Experimental Medicine. 24(1). 66–66. 3 indexed citations
5.
Zhou, Yang, Zhiwei Huang, Shujuan Yu, et al.. (2024). A low bleeding risk thrombolytic agent: citPA5. Cardiovascular Research. 120(10). 1191–1201. 2 indexed citations
6.
Ge, Zilu, Wei Xiong, Dong Wang, et al.. (2023). Comparison of femoral neck system vs. dynamic hip system blade for the treatment of femoral neck fracture in young patients: A retrospective study. Frontiers in Surgery. 10. 1092786–1092786. 3 indexed citations
7.
Leng, Xiaomei, Wei Lin, Shixue Liu, et al.. (2023). Efficacy and safety of tofacitinib in Chinese patients with active psoriatic arthritis: a phase 3, randomised, double-blind, placebo-controlled study. RMD Open. 9(1). e002559–e002559. 15 indexed citations
8.
9.
Shen, Chanjuan, Ting Meng, Joshua D. Ooi, et al.. (2022). Clinical features and prognosis of MPO-ANCA and anti-GBM double-seropositive patients. Frontiers in Immunology. 13. 991469–991469. 9 indexed citations
10.
Meng, Ting, Chanjuan Shen, Joshua D. Ooi, et al.. (2022). The effect of discontinuation of maintenance therapy in Chinese patients with MPO-ANCA associated vasculitis who were in long-term stable remission. Clinical and Experimental Medicine. 23(2). 357–364. 1 indexed citations
11.
Chen, Daxin, Shan Lin, Huajian Gao, et al.. (2022). Qingda granule alleviate angiotensin ⅱ-induced hypertensive renal injury by suppressing oxidative stress and inflammation through NOX1 and NF-κB pathways. Biomedicine & Pharmacotherapy. 153. 113407–113407. 10 indexed citations
12.
Zeng, Yi, et al.. (2022). Radiological predictive factors of transmural intestinal necrosis in acute mesenteric ischemia: systematic review and meta-analysis. European Radiology. 33(4). 2792–2799. 20 indexed citations
13.
Li, Da, Ying Wu, Yuanyuan Zhang, et al.. (2022). Enteral nutrition for children with acute leukemia-related pancreatitis. Nutrition. 103-104. 111810–111810.
14.
Lin, Wei, Jue Fan, Longfei Hu, et al.. (2021). Single-cell analysis of angiotensin-converting enzyme II expression in human kidneys and bladders reveals a potential route of 2019 novel coronavirus infection. Chinese Medical Journal. 134(8). 935–943. 25 indexed citations
15.
Zhao, Xinyan, Yafei He, Jimin Liu, et al.. (2021). Impact of living donor liver with steatosis and idiopathic portal inflammation on clinical outcomes in pediatric liver transplantation: Beijing experience. HepatoBiliary Surgery and Nutrition. 11(3). 340–354. 5 indexed citations
16.
Lin, Wei, Chanjuan Shen, Yong Zhong, et al.. (2021). Glomerular Immune Deposition in MPO-ANCA Associated Glomerulonephritis Is Associated With Poor Renal Survival. Frontiers in Immunology. 12. 625672–625672. 29 indexed citations
17.
Han, Xiaotong, Danhong Peng, Yong Fan, et al.. (2020). Clinical Characteristics and Prognosis of 218 Patients With COVID-19: A Retrospective Study Based on Clinical Classification. Frontiers in Medicine. 7. 485–485. 31 indexed citations
18.
19.
Hou, Jiajie, Dong Xu, Zachary Goodman, et al.. (2011). 716 FIVE-YEAR TELBIVUDINE TREATMENT WITH EFFECTIVE VIRAL SUPPRESSION RESULTS IN RESOLUTION OF LIVER INFLAMMATION AND FIBROSIS REGRESSION IN PATIENTS WITH CHRONIC HEPATITIS B. Journal of Hepatology. 54. S287–S287. 5 indexed citations
20.
Lin, Wei, Min Chen, & Ming‐Hui Zhao. (2009). Follow-up of avidity and titer of anti-myeloperoxidase antibodies in sera from patients with primary ANCA-associated vasculitis. Autoimmunity. 42(3). 198–202. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Qingchun Zeng Breakdown of academic impact, for papers by Jill Moser Breakdown of academic impact, for papers by Elizabeth Kuo Breakdown of academic impact, for papers by Laura Márquez‐Expósito Breakdown of academic impact, for papers by Fernando de la Cuesta Breakdown of academic impact, for papers by Carine M. Boustany‐Kari Breakdown of academic impact, for papers by Julian A. Marschner Breakdown of academic impact, for papers by Martin Kömhoff Breakdown of academic impact, for papers by Stephen I‐Hong Hsu Breakdown of academic impact, for papers by Chun‐Tao Lei
Rankless by CCL
2026